BimEL is an important determinant for induction of anoikis sensitivity by mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitorsHidesuke Fukazawa, Yoshimasa Uehara|Molecular Cancer Therapeutics|2004Cited by 46
Sensitisation of Cancer Cells to MLN8237, an Aurora-A Inhibitor, by YAP/TAZ InactivationYusuke Oku, Yoshimasa Uehara|Anticancer Research|2018Cited by 11